Human protein kinase bgamma polypeptides and a method for disrupting protein kinase bgamma in a non-human
EP1161421A1
Inhibitors of protein tyrosine phosphatase
WO0043387A1
New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
US6329184B1
Crystalline form of activated tartrate-resistant and purple acid phosphatase
SE9904269D0
Use of new responsive elements
AU1901800A
Method for screening for substances which are activators, inhibitors or binders of pkb by the use of a substrate peptide and the use of the substrate peptide
US6436654B1
Methods for identifying compounds that modulate HIF-1α
US6361561B1
Injectable intraocular lens
WO0012070A1
Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder
IL156414D0
Therapeutic formulation for administering tolterodine with controlled release
TWI243852B
Angiogenesis related molecules
WO9964062A1
New therapeutic use of pkb (proteine kinase b) enhancers
US6187813B1
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP1090140A1
Method for screening for substances which are activators or inhibitors of protein kinase b
